| IDEAYA IDEAYA BIOSCIENCES, INC.
87152601 26 Aug 2016 | on 01 Jan 2019 | Small molecule therapeutic pharmaceuticals for the treatment of cancer Class 005 Class 005 Pharmaceutical Products Small molecule therapeutic pharmaceuticals for the treatment of cancer | | | OMCLISVI Ideaya Biosciences, Inc.
98257360 06 Nov 2023 | on 01 Dec 2024 | Pharmaceutical and biological preparations, namely, an orally administ... Class 005 Class 005 Pharmaceutical Products Pharmaceutical and biological preparations, namely, an orally administered protein kinase C (PKC) inhibitor; pharmaceutical and biological preparations for use in oncology for medical treatment purposes; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing cancer, tumors, melanoma, and carcinoma; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing metastatic uveal melanoma, primary uveal melanoma, and cutaneous melanoma; therapeutic agents for targeting genetically defined cancers or tumors having GNAQ or GNA11 gene mutations, and destruction of diseased cells, for medical treatment purposes | | | IMCLISFA Ideaya Biosciences, Inc.
98257351 06 Nov 2023 | on 01 Dec 2024 | Pharmaceutical and biological preparations, namely, an orally administ... Class 005 Class 005 Pharmaceutical Products Pharmaceutical and biological preparations, namely, an orally administered protein kinase C (PKC) inhibitor; pharmaceutical and biological preparations for use in oncology for medical treatment purposes; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing cancer, tumors, melanoma, and carcinoma; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing metastatic uveal melanoma, primary uveal melanoma, and cutaneous melanoma; therapeutic agents for targeting genetically defined cancers or tumors having GNAQ or GNA11 gene mutations, and destruction of diseased cells, for medical treatment purposes | | | UMDARZY Ideaya Biosciences, Inc.
98257354 06 Nov 2023 | on 01 Dec 2024 | Pharmaceutical and biological preparations, namely, an orally administ... Class 005 Class 005 Pharmaceutical Products Pharmaceutical and biological preparations, namely, an orally administered protein kinase C (PKC) inhibitor; pharmaceutical and biological preparations for use in oncology for medical treatment purposes; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing cancer, tumors, melanoma, and carcinoma; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing metastatic uveal melanoma, primary uveal melanoma, and cutaneous melanoma; therapeutic agents for targeting genetically defined cancers or tumors having GNAQ or GNA11 gene mutations, and destruction of diseased cells, for medical treatment purposes | | | UMDARZI Ideaya Biosciences, Inc.
98257358 06 Nov 2023 | on 01 Dec 2024 | Pharmaceutical and biological preparations, namely, an orally administ... Class 005 Class 005 Pharmaceutical Products Pharmaceutical and biological preparations, namely, an orally administered protein kinase C (PKC) inhibitor; pharmaceutical and biological preparations for use in oncology for medical treatment purposes; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing cancer, tumors, melanoma, and carcinoma; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing metastatic uveal melanoma, primary uveal melanoma, and cutaneous melanoma; therapeutic agents for targeting genetically defined cancers or tumors having GNAQ or GNA11 gene mutations, and destruction of diseased cells, for medical treatment purposes | | | OMCLISOS Ideaya Biosciences, Inc.
98257321 06 Nov 2023 | on 01 Dec 2024 | Pharmaceutical and biological preparations, namely, an orally administ... Class 005 Class 005 Pharmaceutical Products Pharmaceutical and biological preparations, namely, an orally administered protein kinase C (PKC) inhibitor; pharmaceutical and biological preparations for use in oncology for medical treatment purposes; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing cancer, tumors, melanoma, and carcinoma; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing metastatic uveal melanoma, primary uveal melanoma, and cutaneous melanoma; therapeutic agents for targeting genetically defined cancers or tumors having GNAQ or GNA11 gene mutations, and destruction of diseased cells, for medical treatment purposes | | | IPIKCYA Ideaya Biosciences, Inc.
98257328 06 Nov 2023 | on 01 Dec 2024 | Pharmaceutical and biological preparations, namely, an orally administ... Class 005 Class 005 Pharmaceutical Products Pharmaceutical and biological preparations, namely, an orally administered protein kinase C (PKC) inhibitor; pharmaceutical and biological preparations for use in oncology for medical treatment purposes; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing cancer, tumors, melanoma, and carcinoma; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing metastatic uveal melanoma, primary uveal melanoma, and cutaneous melanoma; therapeutic agents for targeting genetically defined cancers or tumors having GNAQ or GNA11 gene mutations, and destruction of diseased cells, for medical treatment purposes. | | 
